Document is current

Any future updates will be listed below

The Emerging Therapeutic Promise of SGLT2 Inhibitors in Metabolic Dysfunction-Associated Steatotic Liver Disease

Crossref DOI link: https://doi.org/10.1007/s10620-025-09464-3

Published Online: 2025-10-14

Published Print: 2026-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark